UGX-06

N/A

Report date: 2024/09/06 14:27:47

Base Information

Drug NameUGX-06
Drug Alias NameUGX-06
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGene transference
TargetsUpdating
Therapy Area/IndicationsRetinitis Pigmentosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSuzhou Xingming Youjian Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Xingming Youjian Biotechnology Co LtdThe First Affiliated Hospital Of Soochow University
Inactive CompaniesN/A
Active IndicationsRetinitis Pigmentosa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A